Cumberland Pharmaceuticals Files 8-K
Ticker: CPIX · Form: 8-K · Filed: May 6, 2025 · CIK: 1087294
Sentiment: neutral
Topics: financial-reporting, sec-filing
Related Tickers: CPRX
TL;DR
CPRX filed an 8-K on May 6th, expect financial updates soon.
AI Summary
Cumberland Pharmaceuticals Inc. filed an 8-K on May 6, 2025, reporting on its results of operations and financial condition, as well as financial statements and exhibits. The filing does not contain specific financial figures or operational details within the provided text, but indicates a formal reporting event.
Why It Matters
This filing signifies a formal update from Cumberland Pharmaceuticals Inc. to the SEC regarding its financial status and operations, which is crucial for investors to monitor.
Risk Assessment
Risk Level: low — The filing is a standard procedural report and does not contain information that inherently increases risk.
Key Players & Entities
- CUMBERLAND PHARMACEUTICALS INC. (company) — Registrant
- 0001087294 (company) — Central Index Key
- 2834 (company) — Standard Industrial Classification Code
- May 6, 2025 (date) — Date of Report
FAQ
What specific financial information is being reported in this 8-K?
The provided text indicates the filing pertains to 'Results of Operations and Financial Condition' and 'Financial Statements and Exhibits,' but does not detail the specific figures within this excerpt.
What is the filing date of this 8-K?
The filing date of this 8-K is May 6, 2025.
What is the principal executive office address for Cumberland Pharmaceuticals Inc.?
The principal executive offices are located at 1600 West End Avenue, Suite 1300, Nashville, Tennessee 37203.
What is the telephone number for Cumberland Pharmaceuticals Inc.?
The registrant's telephone number, including area code, is (615) 255-0068.
What is Cumberland Pharmaceuticals Inc.'s Standard Industrial Classification (SIC) code?
Cumberland Pharmaceuticals Inc.'s SIC code is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 6, 2025 regarding CUMBERLAND PHARMACEUTICALS INC (CPIX).